Cancer deal equity bid

A NEW cancer alliance is launching this week to get a fairer deal for the many cancer sufferers who are missing out on new, lifesaving drugs because they can’t afford them.

The National Oncology Alliance, made up of clinicians, patients and pharmaceutical companies, plans to highlight the inequities that exist with patients and lobby the government for fairer treatment.

NOA is calling for changes ahead of the Pharmaceutical Benefits Advisory Committee meeting on Friday.

“It’s unfair. If you had twin brothers, one with melanoma and another with a rare skin cancer called merkle cell, and both were prescribed the same drug, the melanoma brother would pay $39 a month and the other would pay up to $10,000,” said co-chair of NOA Richard Vines, from Rare Cancers Australia.

The original version of this article can be found here.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s